Le cluster Ruiyuan Cao - Zhihong Hu

Terms

2	Ruiyuan Cao
2	Zhihong Hu
2	Mingyue Xu
2	Manli Wang
4	Wu Zhong
2	Pei Hao
2	Xuan Li

Associations

Freq.	Weight	Association
2	1.000	Ruiyuan Cao - Zhihong Hu
2	1.000	Mingyue Xu - Zhihong Hu
2	1.000	Mingyue Xu - Ruiyuan Cao
2	1.000	Manli Wang - Zhihong Hu
2	1.000	Manli Wang - Ruiyuan Cao
2	1.000	Manli Wang - Mingyue Xu
2	0.707	Wu Zhong - Zhihong Hu
2	0.707	Wu Zhong - Xuan Li
2	1.000	Pei Hao - Xuan Li
2	0.707	Ruiyuan Cao - Wu Zhong
2	0.707	Pei Hao - Wu Zhong
2	0.707	Mingyue Xu - Wu Zhong
2	0.707	Manli Wang - Wu Zhong

Documents par ordre de pertinence

000402 (2020)	Manli Wang [République populaire de Chine] ; Ruiyuan Cao [République populaire de Chine] ; Leike Zhang [République populaire de Chine] ; Xinglou Yang [République populaire de Chine] ; Jia Liu [République populaire de Chine] ; Mingyue Xu [République populaire de Chine] ; Zhengli Shi [République populaire de Chine] ; Zhihong Hu [République populaire de Chine] ; Wu Zhong [République populaire de Chine] ; Gengfu Xiao [République populaire de Chine]	Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
000684 (2020)	Jia Liu [République populaire de Chine] ; Ruiyuan Cao [République populaire de Chine] ; Mingyue Xu [République populaire de Chine] ; Xi Wang [République populaire de Chine] ; Huanyu Zhang [République populaire de Chine] ; Hengrui Hu [République populaire de Chine] ; Yufeng Li [République populaire de Chine] ; Zhihong Hu [République populaire de Chine] ; Wu Zhong [République populaire de Chine] ; Manli Wang [République populaire de Chine]	Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro
000633 (2020)	Pei Hao [République populaire de Chine] ; Wu Zhong [République populaire de Chine] ; Shiyang Song [République populaire de Chine] ; Shiyong Fan [République populaire de Chine] ; Xuan Li [République populaire de Chine]	Is SARS-CoV-2 originated from laboratory? A rebuttal to the claim of formation via laboratory recombination.
000767 (2020)	Xintian Xu [République populaire de Chine] ; Ping Chen [République populaire de Chine] ; Jingfang Wang [République populaire de Chine] ; Jiannan Feng [République populaire de Chine] ; Hui Zhou [République populaire de Chine] ; Xuan Li [République populaire de Chine] ; Wu Zhong [République populaire de Chine] ; Pei Hao [République populaire de Chine]	Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Sat Mar 28 17:51:24 2020. Site generation: Sun Jan 31 15:35:48 2021